ACRO Statements on Innovation
The expertise and innovation of ACRO member companies helps speed the clinical trial
process and the development of safe and effective therapies. See below for ACRO’s statements on innovation.
ACRO’s CRO Forum’s paper enables greater collaboration and efficiency through a shared vision of risk based quality management (RBQM).
A survey of ACRO members reveals that Risk-Based Monitoring (RBM) makes clinical trial quality review more efficient and effective.
On 13 March 2020, ACRO released a list of considerations that support clinical trial monitoring oversight during COVID-19.
ACRO’s DCT White Paper provides an overview of considerations for decentralized clinical trials and introduces the Quality-by-Design Manual and Risk-Assessment Template.